KSR1 is a functional protein kinase capable of serine autophosphorylation and direct phosphorylation of MEK1

Experimental Cell Research

Volumn 317, Issue 4, 2011, Pages 452-463

  Goettel, Jeremy A ^a   Liang, Dongchun ^a   Hilliard, Valda C ^a   Edelblum, Karen L ^a   Broadus, Matthew R ^a   Gould, Kathleen L ^a   Hanks, Steven K ^a   Polk, D Brent ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; ERK; KSR1; MAPK; MEK; TNF

Indexed keywords

KINASE SUPPRESSOR OF RAS 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MYELIN BASIC PROTEIN; PROTEIN KINASE; SERINE; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; AUTOPHOSPHORYLATION; CELL LOSS; COLON MUCOSA; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ESCHERICHIA COLI; MOUSE; NONHUMAN; PRIORITY JOURNAL; WILD TYPE;

ESCHERICHIA COLI;

EID: 78651441816     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2010.11.018     Document Type: Article

References (71)

1. Cheng Y., Qiu F., Tashiro S.-i., Onodera S., Ikejima T. ERK and JNK mediate TNFalpha-induced p53 activation in apoptotic and autophagic L929 cell death. Biochem. Biophys. Res. Commun. 2008, 376:483-488.
2. Kaiser G.C., Yan F., Polk D.B. Conversion of TNF alpha from antiproliferative to proliferative ligand in mouse intestinal epithelial cells by regulating mitogen-activated protein kinase. Exp. Cell Res. 1999, 249:349-358.
3. Qui M.S., Green S.H. PC12 cell neuronal differentiation is associated with prolonged p21ras activity and consequent prolonged ERK activity. Neuron 1992, 9:705-717.
4. Kanakura Y., Druker B., Wood K.W., Mamon H.J., Okuda K., Roberts T.M., Griffin J.D. Granulocyte-macrophage colony-stimulating factor and interleukin-3 induce rapid phosphorylation and activation of the proto-oncogene Raf-1 in a human factor-dependent myeloid cell line. Blood 1991, 77:243-248.
5. Andreyev H.J., Norman A.R., Cunningham D., Oates J., Dix B.R., Iacopetta B.J., Young J., Walsh T., Ward R., Hawkins N., Beranek M., Jandik P., Benamouzig R., Jullian E., Laurent-Puig P., Olschwang S., Muller O., Hoffmann I., Rabes H.M., Zietz C., Troungos C., Valavanis C., Yuen S.T., Ho J.W., Croke C.T., O'Donoghue D.P., Giaretti W., Rapallo A., Russo A., Bazan V., Tanaka M., Omura K., Azuma T., Ohkusa T., Fujimori T., Ono Y., Pauly M., Faber C., Glaesener R., de Goeij A.F., Arends J.W., Andersen S.N., Lövig T., Breivik J., Gaudernack G., Clausen O.P., De Angelis P.D., Meling G.I., Rognum T.O., Smith R., Goh H.S., Font A., Rosell R., Sun X.F., Zhang H., Benhattar J., Losi L., Lee J.Q., Wang S.T., Clarke P.A., Bell S., Quirke P., Bubb V.J., Piris J., Cruickshank N.R., Morton D., Fox J.C., Al-Mulla F., Lees N., Hall C.N., Snary D., Wilkinson K., Dillon D., Costa J., Pricolo V.E., Finkelstein S.D., Thebo J.S., Senagore A.J., Halter S.A., Wadler S., Malik S., Krtolica K., Urosevic N. Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study. Br. J. Cancer 2001, 85:692-696.
6. Therrien M., Chang H.C., Solomon N.M., Karim F.D., Wassarman D.A., Rubin G.M. KSR, a novel protein kinase required for RAS signal transduction. Cell 1995, 83:879-888.
7. Sundaram M., Han M. The C. elegans ksr-1 gene encodes a novel Raf-related kinase involved in Ras-mediated signal transduction. Cell 1995, 83:889-901.
8. Kornfeld K., Hom D.B., Horvitz H.R. The ksr-1 gene encodes a novel protein kinase involved in Ras-mediated signaling in C. elegans. Cell 1995, 83:903-913.
9. Stewart S., Sundaram M., Zhang Y., Lee J., Han M., Guan K.L. Kinase suppressor of Ras forms a multiprotein signaling complex and modulates MEK localization. Mol. Cell. Biol. 1999, 19:5523-5534.
10. Yu W., Fantl W.J., Harrowe G., Williams L.T. Regulation of the MAP kinase pathway by mammalian Ksr through direct interaction with MEK and ERK. Curr. Biol. 1998, 8:56-64.
11. Denouel-Galy A., Douville E.M., Warne P.H., Papin C., Laugier D., Calothy G., Downward J., Eychène A. Murine Ksr interacts with MEK and inhibits Ras-induced transformation. Curr. Biol. 1998, 8:46-55.
12. Hanks S.K., Quinn A.M., Hunter T. The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. Science 1988, 241:42-52.
13. Hanks S.K., Hunter T. Protein kinases 6. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification. FASEB J. 1995, 9:576-596.
14. Kamps M.P., Sefton B.M. Neither arginine nor histidine can carry out the function of lysine-295 in the ATP-binding site of p60src. Mol. Cell. Biol. 1986, 6:751-757.
15. Gibbs C.S., Zoller M.J. Rational scanning mutagenesis of a protein kinase identifies functional regions involved in catalysis and substrate interactions. J. Biol. Chem. 1991, 266:8923-8931.
16. Snyder M.A., Bishop J.M., McGrath J.P., Levinson A.D. A mutation at the ATP-binding site of pp 60v-src abolishes kinase activity, transformation, and tumorigenicity. Mol. Cell. Biol. 1985, 5:1772-1779.
17. Ebina Y., Araki E., Taira M., Shimada F., Mori M., Craik C.S., Siddle K., Pierce S.B., Roth R.A., Rutter W.J. Replacement of lysine residue 1030 in the putative ATP-binding region of the insulin receptor abolishes insulin- and antibody-stimulated glucose uptake and receptor kinase activity. Proc. Natl Acad. Sci. USA 1987, 84:704-708.
18. Cotten M., Stegmueller K., Eickhoff J., Hanke M., Herzberger K., Herget T., Choidas A., Daub H., Godl K. Exploiting features of adenovirus replication to support mammalian kinase production. Nucleic Acids Res. 2003, 31:e128.
19. Müller J., Cacace A.M., Lyons W.E., McGill C.B., Morrison D.K. Identification of B-KSR1, a novel brain-specific isoform of KSR1 that functions in neuronal signaling. Mol. Cell. Biol. 2000, 20:5529-5539.
20. Xu B., English J.M., Wilsbacher J.L., Stippec S., Goldsmith E.J., Cobb M.H. WNK1, a novel mammalian serine/threonine protein kinase lacking the catalytic lysine in subdomain II. J. Biol. Chem. 2000, 275:16795-16801.
21. Zhang Y., Yao B., Delikat S., Bayoumy S., Lin X.H., Basu S., McGinley M., Chan-Hui P.Y., Lichenstein H., Kolesnick R. Kinase suppressor of Ras is ceramide-activated protein kinase. Cell 1997, 89:63-72.
22. Xing H.R., Lozano J., Kolesnick R. Epidermal growth factor treatment enhances the kinase activity of kinase suppressor of Ras. J. Biol. Chem. 2000, 275:17276-17280.
23. Yan F., John S.K., Wilson G., Jones D.S., Washington M.K., Polk D.B. Kinase suppressor of Ras-1 protects intestinal epithelium from cytokine-mediated apoptosis during inflammation. J. Clin. Investig. 2004, 114:1272-1280.
24. Michaud N.R., Therrien M., Cacace A., Edsall L.C., Spiegel S., Rubin G.M., Morrison D.K. KSR stimulates Raf-1 activity in a kinase-independent manner. Proc. Natl Acad. Sci. USA 1997, 94:12792-12796.
25. Volle D.J., Fulton J.A., Chaika O.V., McDermott K., Huang H., Steinke L.A., Lewis R.E. Phosphorylation of the kinase suppressor of Ras by associated kinases. Biochemistry 1999, 38:5130-5137.
26. Rahmsdorf H.J., Pai S.H., Ponta H., Herrlich P., Roskoski R., Schweiger M., Studier F.W. Protein kinase induction in Escherichia coli by bacteriophage T7. Proc. Natl Acad. Sci. USA 1974, 71:586-589.
27. Whitehead R.H., VanEeden P.E., Noble M.D., Ataliotis P., Jat P.S. Establishment of conditionally immortalized epithelial cell lines from both colon and small intestine of adult H-2Kb-tsA58 transgenic mice. Proc. Natl Acad. Sci. USA 1993, 90:587-591.
28. Corredor J., Yan F., Shen C.C., Tong W., John S.K., Wilson G., Whitehead R., Polk D.B. Tumor necrosis factor regulates intestinal epithelial cell migration by receptor-dependent mechanisms. Am. J. Physiol. Cell Physiol. 2003, 284:C953-C961.
29. Duclos B., Marcandier S., Cozzone A.J. Chemical properties and separation of phosphoamino acids by thin-layer chromatography and/or electrophoresis. Meth. Enzymol. 1991, 201:10-21.
30. Breese E.J., Michie C.A., Nicholls S.W., Murch S.H., Williams C.B., Domizio P., Walker-Smith J.A., MacDonald T.T. Tumor necrosis factor alpha-producing cells in the intestinal mucosa of children with inflammatory bowel disease. Gastroenterology 1994, 106:1455-1466.
31. Kontakou M., Sturgess R.P., Przemioslo R.T., Limb G.A., Nelufer J.M., Ciclitira P.J. Detection of interferon gamma mRNA in the mucosa of patients with coeliac disease by in situ hybridisation. Gut 1994, 35:1037-1041.
32. Zhou Z., Gengaro P., Wang W., Wang X.-q., Li C., Faubel S., Rivard C., Schrier R.W. Role of NF-kappaB and PI 3-kinase/Akt in TNF-alpha-induced cytotoxicity in microvascular endothelial cells. Am. J. Physiol. Renal. Physiol. 2008, 295:F932-F941.
33. Xing H.R., Campodonico L., Kolesnick R. The kinase activity of kinase suppressor of Ras1 (KSR1) is independent of bound MEK. J. Biol. Chem. 2004, 279:26210-26214.
34. Yan F., Polk D.B. Kinase suppressor of Ras is necessary for tumor necrosis factor alpha activation of extracellular signal-regulated kinase/mitogen-activated protein kinase in intestinal epithelial cells. Cancer Res. 2001, 61:963-969.
35. Alessi D.R., Saito Y., Campbell D.G., Cohen P., Sithanandam G., Rapp U., Ashworth A., Marshall C.J., Cowley S. Identification of the sites in MAP kinase kinase-1 phosphorylated by p74raf-1. EMBO J. 1994, 13:1610-1619.
36. Zheng C.F., Guan K.L. Activation of MEK family kinases requires phosphorylation of two conserved Ser/Thr residues. EMBO J. 1994, 13:1123-1131.
37. Nadeau K., Das A., Walsh C.T. Hsp90 chaperonins possess ATPase activity and bind heat shock transcription factors and peptidyl prolyl isomerases. J. Biol. Chem. 1993, 268:1479-1487.
38. Yin X., Zafrullah M., Lee H., Haimovitz-Friedman A., Fuks Z., Kolesnick R. A ceramide-binding C1 domain mediates kinase suppressor of ras membrane translocation. Cell. Physiol. Biochem. 2009, 24:219-230.
39. Siskind L.J., Colombini M. The lipids C2- and C16-ceramide form large stable channels. Implications for apoptosis. J. Biol. Chem. 2000, 275:38640-38644.
40. Kishimoto A., Nishiyama K., Nakanishi H., Uratsuji Y., Nomura H., Takeyama Y., Nishizuka Y. Studies on the phosphorylation of myelin basic protein by protein kinase C and adenosine 3':5'-monophosphate-dependent protein kinase. J. Biol. Chem. 1985, 260:12492-12499.
41. Shoji S., Ohnishi J., Funakoshi T., Fukunaga K., Miyamoto E., Ueki H., Kubota Y. Phosphorylation sites of bovine brain myelin basic protein phosphorylated with Ca2+-calmodulin-dependent protein kinase from rat brain. J. Biochem. 1987, 102:1113-1120.
42. Erickson A.K., Payne D.M., Martino P.A., Rossomando A.J., Shabanowitz J., Weber M.J., Hunt D.F., Sturgill T.W. Identification by mass spectrometry of threonine 97 in bovine myelin basic protein as a specific phosphorylation site for mitogen-activated protein kinase. J. Biol. Chem. 1990, 265:19728-19735.
43. Zafrullah M., Yin X., Haimovitz-Friedman A., Fuks Z., Kolesnick R. Kinase suppressor of Ras transphosphorylates c-Raf-1. Biochem. Biophys. Res. Commun. 2009, 390:434-440.
44. Xing H.R., Kolesnick R. Kinase suppressor of Ras signals through Thr269 of c-Raf-1. J. Biol. Chem. 2001, 276:9733-9741.
45. McKay M.M., Morrison D.K. Caspase-dependent cleavage disrupts the ERK cascade scaffolding function of KSR1. J. Biol. Chem. 2007, 282:26225-26234.
46. Shimamura A., Ballif B.A., Richards S.A., Blenis J. Rsk1 mediates a MEK-MAP kinase cell survival signal. Curr. Biol. 2000, 10:127-135.
47. Ripple M.O., Kalmadi S., Eastman A. Inhibition of either phosphatidylinositol 3-kinase/Akt or the mitogen/extracellular-regulated kinase, MEK/ERK, signaling pathways suppress growth of breast cancer cell lines, but MEK/ERK signaling is critical for cell survival. Breast Cancer Res. Treat. 2005, 93:177-188.
48. Erhardt P., Schremser E.J., Cooper G.M. B-Raf inhibits programmed cell death downstream of cytochrome c release from mitochondria by activating the MEK/Erk pathway. Mol. Cell. Biol. 1999, 19:5308-5315.
49. Le Gall M., Chambard J.C., Breittmayer J.P., Grall D., Pouysségur J., Van Obberghen-Schilling E. The p42/p44 MAP kinase pathway prevents apoptosis induced by anchorage and serum removal. Mol. Biol. Cell 2000, 11:1103-1112.
50. Lin J., Harding A., Giurisato E., Shaw A.S. KSR1 modulates the sensitivity of mitogen-activated protein kinase pathway activation in T cells without altering fundamental system outputs. Mol. Cell. Biol. 2009, 29:2082-2091.
51. Fusello A.M., Mandik-Nayak L., Shih F., Lewis R.E., Allen P.M., Shaw A.S. The MAPK scaffold kinase suppressor of Ras is involved in ERK activation by stress and proinflammatory cytokines and induction of arthritis. J. Immunol. 2006, 177:6152-6158.
52. Giroux S., Tremblay M., Bernard D., Cardin-Girard J.F., Aubry S., Larouche L., Rousseau S., Huot J., Landry J., Jeannotte L., Charron J. Embryonic death of Mek1-deficient mice reveals a role for this kinase in angiogenesis in the labyrinthine region of the placenta. Curr. Biol. 1999, 9:369-372.
53. Scholl F.A., Dumesic P.A., Barragan D.I., Harada K., Bissonauth V., Charron J., Khavari P.A. Mek1/2 MAPK kinases are essential for Mammalian development, homeostasis, and Raf-induced hyperplasia. Dev. Cell 2007, 12:615-629.
54. Rajakulendran T., Sahmi M., Lefrançois M., Sicheri F., Therrien M. A dimerization-dependent mechanism drives RAF catalytic activation. Nature 2009, 461:542-545.
55. Liu J., Mathias S., Yang Z., Kolesnick R.N. Renaturation and tumor necrosis factor-alpha stimulation of a 97-kDa ceramide-activated protein kinase. J. Biol. Chem. 1994, 269:3047-3052.
56. McPherson R.A., Harding A., Roy S., Lane A., Hancock J.F. Interactions of c-Raf-1 with phosphatidylserine and 14-3-3. Oncogene 1999, 18:3862-3869.
57. Xing H., Kornfeld K., Muslin A.J. The protein kinase KSR interacts with 14-3-3 protein and Raf. Curr. Biol. 1997, 7:294-300.
58. Cacace A.M., Michaud N.R., Therrien M., Mathes K., Copeland T., Rubin G.M., Morrison D.K. Identification of constitutive and ras-inducible phosphorylation sites of KSR: implications for 14-3-3 binding, mitogen-activated protein kinase binding, and KSR overexpression. Mol. Cell. Biol. 1999, 19:229-240.
59. Dobrowsky R.T., Hannun Y.A. Ceramide stimulates a cytosolic protein phosphatase. J. Biol. Chem. 1992, 267:5048-5051.
60. Müller J., Ory S., Copeland T., Piwnica-Worms H., Morrison D.K. C-TAK1 regulates Ras signaling by phosphorylating the MAPK scaffold, KSR1. Mol. Cell 2001, 8:983-993.
61. Hartsough M.T., Morrison D.K., Salerno M., Palmieri D., Ouatas T., Mair M., Patrick J., Steeg P.S. Nm23-H1 metastasis suppressor phosphorylation of kinase suppressor of Ras via a histidine protein kinase pathway. J. Biol. Chem. 2002, 277:32389-32399.
62. Roy F., Laberge G., Douziech M., Ferland-McCollough D., Therrien M. KSR is a scaffold required for activation of the ERK/MAPK module. Genes Dev. 2002, 16:427-438.
63. Boerth N.J., Lincoln T.M. Expression of the catalytic domain of cyclic GMP-dependent protein kinase in a baculovirus system. FEBS Lett. 1994, 342:255-260.
64. Hecht G., Pestic L., Nikcevic G., Koutsouris A., Tripuraneni J., Lorimer D.D., Nowak G., Guerriero V., Elson E.L., Lanerolle P.D. Expression of the catalytic domain of myosin light chain kinase increases paracellular permeability. Am. J. Physiol. 1996, 271:C1678-C1684.
65. Kinstrie R., Luebbering N., Miranda-Saavedra D., Sibbet G., Han J., Lochhead P.A., Cleghon V. Characterization of a domain that transiently converts class 2 DYRKs into intramolecular tyrosine kinases. Sci. Signal. 2010, 3:ra16.
66. Xu S., Robbins D., Frost J., Dang A., Lange-Carter C., Cobb M.H. MEKK1 phosphorylates MEK1 and MEK2 but does not cause activation of mitogen-activated protein kinase. Proc. Natl Acad. Sci. USA 1995, 92:6808-6812.
67. Sugimoto T., Stewart S., Han M., Guan K.L. The kinase suppressor of Ras (KSR) modulates growth factor and Ras signaling by uncoupling Elk-1 phosphorylation from MAP kinase activation. EMBO J. 1998, 17:1717-1727.
68. Therrien M., Michaud N.R., Rubin G.M., Morrison D.K. KSR modulates signal propagation within the MAPK cascade. Genes Dev. 1996, 10:2684-2695.
69. Boudeau J., Miranda-Saavedra D., Barton G.J., Alessi D.R. Emerging roles of pseudokinases. Trends Cell Biol. 2006, 16:443-452.
70. Abe Y., Matsumoto S., Wei S., Nezu K., Miyoshi A., Kito K., Ueda N., Shigemoto K., Hitsumoto Y., Nikawa J., Enomoto Y. Cloning and characterization of a p53-related protein kinase expressed in interleukin-2-activated cytotoxic T-cells, epithelial tumor cell lines, and the testes. J. Biol. Chem. 2001, 276:44003-44011.
71. Rutgeerts P., Van Assche G., Vermeire S. Review article: Infliximab therapy for inflammatory bowel disease-seven years on. Aliment. Pharmacol. Ther. 2006, 23:451-463.